- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
Offering a combination of personalized customization, enhanced imaging quality and dose efficiency considerations, the Zenition 30 mobile C-arm device has garnered 510(k) clearance from the Food and Drug Administration (FDA).
Deemphasizing the need for manual adjustments, the Zenition 30 mobile C-arm device features automated adjustments to the preferred settings of clinicians and as well as accessible push buttons on the flat detector that allow necessary adjustments to horizontal, orbital and/or rotational positioning changes of the C-arm, according to Philips, the manufacturer of the Zenition 30 mobile C-arm device.
The Zenition 30 mobile C-arm device features automated adjustments to the preferred settings of clinicians as well as accessible push buttons on the flat detector that allow necessary adjustments to horizontal, orbital and/or rotational positioning changes of the C-arm. (Image courtesy of Philips.)
Philips noted that other features of the device include low-dose modes for pediatric patients, enhanced vascular imaging with digital subtraction angiography (DSA) procedures, and automated imaging adjustments with the Philips MetalSmart software that eliminate blooming in the imaging of patients with metal implants.
“Based on our Zenition platform’s proven ease of use and workflow efficiency, the new Zenition 30 offers a unique combination of personalized control and image clarity to enhance the speed and accuracy of decision making for a range of clinical procedures at a price point that meets today’s economic and business goals,” said Mark Stoffels, the general manager of Philips Image Guided Therapy Systems.
Study: AI Bolsters Sensitivity for Pneumothorax on CXR and Significantly Reduces Reporting Time
October 30th 2024For clinically actionable pneumothorax, an artificial intelligence algorithm demonstrated a 93 percent AUC and a 96 percent specificity rate in a study involving chest X-rays from over 27,000 adults.
Comparative Study Evaluates AI Products for Detecting Tuberculosis on Chest X-Rays
August 9th 2024At a 90 percent threshold for sensitivity, Lunit’s Insight CXR and the Nexus CXR software from Nexus demonstrated the highest specificity rates for tuberculosis (TB) detection in a patient population with a high prevalence of TB and HIV.
